Plain-English translation of NCT07106970 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding extra ablation lines to a standard heart procedure — called pulmonary vein isolation — improves how well the treatment works for persistent atrial fibrillation. Atrial fibrillation is a condition where your heart's upper chambers beat irregularly, which can cause symptoms like heart palpitations, shortness of breath, and fatigue. The study will compare two groups: one receiving the standard procedure alone, and another receiving the standard procedure plus additional ablation lines in other areas of the heart.
Persistent atrial fibrillation is often resistant to medications, and doctors want to know if adding extra ablation lines to the standard procedure can help more patients stay in normal heart rhythm long-term. This trial will help determine the best ablation strategy for people whose symptoms haven't improved with medication alone.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the standard ablation procedure alone or the standard procedure plus additional ablation lines. The procedure itself is done in a hospital under sedation, using energy to create small scars in your heart to block irregular signals. After the procedure, you'll have follow-up visits at discharge, one month, and then every three months for up to one year to monitor your heart rhythm and symptoms.
AI-generated summary from trial data · Jun 21, 2026 · Not medical advice
China
Sponsor
Boston Scientific Corporation
Enrollment target
~640 participants
Started
August 2025
Primary completion
September 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Taimin Yue
Beijing Anzhen Hospital of the Capital University of Medical Sciences
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.